Abiopharma

General Announcement: Commencement of Consent Solicitation Exercise for S$100,000,000 3.25% Guaranteed Bonds Due 2027

Scrip Election/ Distribution/ DRP:

Scrip Election/ Distribution/ DRP:

Scrip Election/ Distribution/ DRP:

Asset Acquisitions and Disposals: Acquisition of Shares by Wholly-Owned Subsidiary - Completion of Proposed Acquisition

Ceasing to be a substantial holder

Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: June Shipment, Sales and Deliveries Hit 242 units, Company Plans to Raise Yearly Shipment Target to 2,000 Units and Becomes the “Star of the Show” at the Automate Conference

Events and transactions

BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children Living with Achondroplasia

Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve paediatric patients with hypophosphatasia at week 25 in MULBERRY Phase II